Sat.Jan 21, 2023 - Fri.Jan 27, 2023

article thumbnail

Five Actionable Steps To Elevate Your Sales Skills For The New Year

Integrity Solutions

The past several years have certainly tested the mettle of even the most experienced salespeople and sales managers.

Sales 86
article thumbnail

BMS settles lawsuit with two fired employees who refused COVID vaccines

Fierce Pharma

BMS settles lawsuit with two fired employees who refused COVID vaccines kdunleavy Thu, 01/26/2023 - 14:30

Pharma 361
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

FDA pulls AZ’s Evusheld for COVID, citing lack of efficacy

pharmaphorum

AstraZeneca’s revenue boost from COVID-19 therapy Evusheld looks set to be curbed early, as the FDA withdraws authorisation for the antibody on the grounds that it is ineffective against most subvariants now circulating in the US.

FDA 135
article thumbnail

Why Are Patients So Angry? Plus, Frontliner Tips for Health Leaders

Healthcare Success

It’s not your imagination. People really are ruder to each other these days. The pandemic, economy, political unrest, war, and continued uncertainty have taken—and continue to take—a toll on people’s mental health. These all contribute to stress, anxiety, frustration, and anger.

article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

This webinar will go over the FDA's guidance on pharmacological and toxicological considerations for optimizing doses for prescription drugs.

article thumbnail

12 Predictions for Non-Personal HCP Promotion in 2023

PM360

As 2023 gets underway, social media is strong and ascendant as an everyday promotional channel for healthcare providers (HCPs). Seventy percent of HCPs report actively using social channels for professional purposes.

More Trending

article thumbnail

A new dawn of the genomic age: five areas set to be transformed in 2023

pharmaphorum

2022 was a banner year for genomics. In March, the collaborative T2T consortium published the first complete telomere-to-telomere sequence of the human genome, filling in the last 8% of the 3 billion base pairs that make up our DNA.

article thumbnail

Virtual Patient Engagement Program: A Customer Story

Impetus Digital

O ur client wanted to better understand the needs, preferences, and treatment gaps among adult patients with a rare genetic disease in the USA.

article thumbnail

Educating the Next Generation of Nurses in the Metaverse

PM360

While the metaverse may seem like an unlikely place to train new nursing students, in actuality, all signs point to it as the next frontier for today’s nursing education programs.

Education 101
article thumbnail

Merck's Keytruda dealt another blow in prostate cancer but readies new challenge to AZ's Imfinzi

Fierce Pharma

Merck's Keytruda dealt another blow in prostate cancer but readies new challenge to AZ's Imfinzi aliu Wed, 01/25/2023 - 10:17

Pharma 306
article thumbnail

Patient centricity and the changing pharmaceutical vista

pharmaphorum

Late last year, pharmaphorum caught up with Dr Karen Mullen, chief medical officer and VP of clinical & medical affairs at global drug development consultancy Boyds.

Patients 111
article thumbnail

Natco Pharma Limited -Walk-In Interview for Multiple Positions On 28th Jan’ 2023

Pharma Pathway

Natco Pharma Limited -Walk-In Interview for Multiple Positions On 28th Jan’ 2023 Job Description Natco Pharma Limited is a vertically integrated and R&D focused pharmaceutical company engaged in developing, manufacturing and marketing of finished dosage formulation (“FDF”) and active pharmaceutical ingredients (“APIs”).

article thumbnail

AstraZeneca’s newest asthma launch fills a gap as generics chip away at respiratory flagships

PharmaVoice

A longtime leader in the respiratory space, AstraZeneca has hammered another stake in the ground with its newest asthma treatment, Airsupra

98
article thumbnail

With FDA approval for Jaypirca, Eli Lilly introduces new BTK blood cancer drug

Fierce Pharma

With FDA approval for Jaypirca, Eli Lilly introduces new BTK blood cancer drug aliu Fri, 01/27/2023 - 15:29

FDA 279
article thumbnail

J&J copay lawsuit against drug benefit firm gets green light

pharmaphorum

Johnson & Johnson has been cleared to continue a lawsuit filed last year against drug benefit programme SaveOnSP, which claims it defrauded a payment assistance programme for patients out of “at least $100 million.”

Insurance 105
article thumbnail

MSN Laboratories Pvt. Ltd-Walk-In Drive for Freshers & Experienced On 29th Jan’ 2023

Pharma Pathway

MSN Laboratories Pvt. Ltd-Walk-In Drive for Freshers & Experienced On 29th Jan’ 2023 Job Description MSN Laboratories Pvt.

article thumbnail

Able Medical Announces Launch of Valkyrie® Looped Sternotomy Sutures

Legacy MEDSearch

Able Medical Devices announced the launch of Valkyrie® Looped Sternotomy Sutures. The stainless-steel looped wire sutures are used to close a patient’s chest after open heart surgery.

Medical 98
article thumbnail

After years of back-and-forth, Gilead's CAR-T Yescarta sways England's cost watchdog NICE

Fierce Pharma

After years of back-and-forth, Gilead's CAR-T Yescarta sways England's cost watchdog NICE fkansteiner Wed, 01/25/2023 - 18:51

Pharma 243
article thumbnail

Tackling ongoing staffing burnout rates through AI-enabled precision oncology

pharmaphorum

The emergence of COVID-19 resulted in staffing challenges that have continued to have a sustained, negative impact on clinical trial workflows.

article thumbnail

Aurobindo Pharma-Walk-In Interviews for Quality Assurance/ Quality Control On 28th Jan’ 2023

Pharma Pathway

Aurobindo Pharma-Walk-In Interviews for Quality Assurance/ Quality Control On 28th Jan’ 2023 Job Description Company Profile: Aurobindo Pharma Ltd’ (APL). APL is a growing India multinational pharmaceutical manufacturing firm with turnover of over US$2.8

article thumbnail

Nvidia’s AI Tech Designs Proteins Never Seen in Nature, Pointing Way to New Therapies

MedCity News

A collaboration between Nvidia and startup Evozyne was able to produce novel versions of a human protein never before seen in nature but with enhanced function and the same safety as native protein. The research lays the groundwork for potential new therapies for a rare inherited disorder.

Safety 140
article thumbnail

Time to shine, biosims: Amgen's Amjevita readies long-awaited assault on AbbVie's Humira

Fierce Pharma

Time to shine, biosims: Amgen's Amjevita readies long-awaited assault on AbbVie's Humira zbecker Fri, 01/27/2023 - 11:50

Pharma 238
article thumbnail

How Moderna kept diversity in mind amid vaccine development

pharmaphorum

In the newest episode of the pharmaphorum podcast, editor-in-chief Jonah Comstock speaks with Jameka Hill, senior director of clinical trial health equity at Moderna.

Pharma 105
article thumbnail

Sun Pharma- Walk-In Drive for Production/R&D/ Process Development On 28th Jan’ 2023

Pharma Pathway

Sun Pharma- Walk-In Drive for Production/R&D/ Process Development On 28th Jan’ 2023 Job Description Walk-In Interview for Production/R&D/ Process Development Department: Production/R&D/ Process Development Division: API Education: M.Sc/ B.E

article thumbnail

The Rise of NP and PA Influence in 2022 and What’s Ahead

PM360

The past few years have propelled nurse practitioners (NPs) and physician associates (PAs) into the spotlight. With widespread physician and caregiver shortages nationwide, burnout and lingering pandemic-related issues, NPs and PAs are leading the charge in healthcare.

article thumbnail

J&J, Legend's Carvykti hits goal in earlier myeloma, escalates CAR-T showdown with Bristol Myers' Abecma

Fierce Pharma

J&J, Legend's Carvykti hits goal in earlier myeloma, escalates CAR-T showdown with Bristol Myers' Abecma aliu Fri, 01/27/2023 - 11:02

Pharma 217
article thumbnail

ABPI code updated with first social media guidance

pharmaphorum

Guidance on the way pharma companies communicate about prescription medicines has been updated in the UK to cover use of social media channels for the first time.

Media 105
article thumbnail

Neuland Laboratories Pvt. Ltd-Walk-In Interview for Freshers & Experienced On 28th Jan’ 2023

Pharma Pathway

Neuland Laboratories Pvt. Ltd-Walk-In Interview for Freshers & Experienced On 28th Jan’ 2023 Job Description Walk-In Interviews for Production & Production Documentation @ Neuland Laboratories Pvt.

Pharma 98
article thumbnail

5 Best Practices for Getting Music Right in Pharma Marketing

PM360

Can you HEAR it? As today’s consumers digest content across an increasingly crowded landscape of platforms and channels, pharmaceutical marketing becomes an exercise of cutting through the noise, both figuratively and literally.

article thumbnail

Bristol Myers doubles down in immuno-oncology patent fight with AZ, this time targeting Imjudo

Fierce Pharma

Bristol Myers doubles down in immuno-oncology patent fight with AZ, this time targeting Imjudo fkansteiner Tue, 01/24/2023 - 16:13

Pharma 216
article thumbnail

Breaking through the forecasting fog – 3 trends that will impact critical medicine supply in 2023

pharmaphorum

As the legendary investor Warren Buffett once said, forecasts about the future usually tell you more about the forecaster than they do about the future.

Medicine 105
article thumbnail

Aspiro Pharma -Walk-In Interviews for Engineering Department On 29th Jan’ 2023

Pharma Pathway

Aspiro Pharma -Walk-In Interviews for Engineering Department On 29th Jan’ 2023 Job Description Greetings from Aspiro Pharma !!! Walk-In Interviews for Engineering Department @ Aspiro Pharma Department: Engineering Position: Officer – Sr.

article thumbnail

Major study on DMT shows promise for depression

European Pharmaceutical Review

The first major study on the efficacy of DMT in treating any mental health condition showed a remission rate of 57 percent following a single dose, in a Phase IIa trial for major depressive disorder (MDD).

article thumbnail

FDA advisors vote to standardize COVID vaccines as bivalent, stump for more data

Fierce Pharma

FDA advisors vote to standardize COVID vaccines as bivalent, stump for more data kdunleavy Fri, 01/27/2023 - 10:01

FDA 214